Vincerx Pharma Statistics

Total Valuation

Vincerx Pharma has a market cap or net worth of $9.25 million. The enterprise value is $801,006.

Market Cap	9.25M
Enterprise Value	801,006

Important Dates

The last earnings date was Tuesday, November 12, 2024, before market open.

Earnings Date	Nov 12, 2024
Ex-Dividend Date	n/a

Share Statistics

Vincerx Pharma has 33.56 million shares outstanding. The number of shares has increased by 49.39% in one year.

Current Share Class	33.56M
Shares Outstanding	33.56M
Shares Change (YoY)	+49.39%
Shares Change (QoQ)	+52.91%
Owned by Insiders (%)	11.19%
Owned by Institutions (%)	18.23%
Float	27.59M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	0.95
P/TBV Ratio	1.02
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 2.17, with a Debt / Equity ratio of 0.18.

Current Ratio	2.17
Quick Ratio	2.06
Debt / Equity	0.18
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -217.55% and return on invested capital (ROIC) is -120.37%.

Return on Equity (ROE)	-217.55%
Return on Assets (ROA)	-85.42%
Return on Capital (ROIC)	-120.37%
Revenue Per Employee	n/a
Profits Per Employee	-$643,571
Employee Count	42
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -58.93% in the last 52 weeks. The beta is 1.27, so Vincerx Pharma's price volatility has been higher than the market average.

Beta (5Y)	1.27
52-Week Price Change	-58.93%
50-Day Moving Average	0.48
200-Day Moving Average	1.50
Relative Strength Index (RSI)	26.32
Average Volume (20 Days)	374,561

Short Selling Information

The latest short interest is 813,840, so 2.43% of the outstanding shares have been sold short.

Short Interest	813,840
Short Previous Month	837,284
Short % of Shares Out	2.43%
Short % of Float	2.95%
Short Ratio (days to cover)	0.80

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-28.17M
Pretax Income	-28.90M
Net Income	-27.03M
EBITDA	-28.12M
EBIT	-28.17M
Earnings Per Share (EPS)	-$0.86

Full Income Statement

Balance Sheet

The company has $10.09 million in cash and $1.64 million in debt, giving a net cash position of $8.45 million or $0.25 per share.

Cash & Cash Equivalents	10.09M
Total Debt	1.64M
Net Cash	8.45M
Net Cash Per Share	$0.25
Equity (Book Value)	9.11M
Book Value Per Share	0.29
Working Capital	6.32M

Full Balance Sheet

Cash Flow

Operating Cash Flow	-27.97M
Capital Expenditures	n/a
Free Cash Flow	-27.97M
FCF Per Share	-$0.83

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

Vincerx Pharma does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-49.39%
Shareholder Yield	-49.39%
Earnings Yield	-292.28%
FCF Yield	-302.39%

Analyst Forecast

The average price target for Vincerx Pharma is $2.00, which is 625.69% higher than the current price. The consensus rating is "Buy".

Price Target	$2.00
Price Target Difference	625.69%
Analyst Consensus	Buy
Analyst Count	2
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	-16.73%

Stock Forecasts

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	n/a